THE PHARMACOKINETICS OF FLUTAMIDE AND ITS MAJOR METABOLITES AFTER A SINGLE ORAL DOSE AND DURING CHRONIC TREATMENT

被引：100

作者：

SCHULZ, M

SCHMOLDT, A

DONN, F

BECKER, H

机构：

[1] UNIV HAMBURG,INST LEGAL MED,BUTENFELD 34,D-2000 HAMBURG 54,FED REP GER

[2] UNIV HAMBURG,DEPT UROL,D-2000 HAMBURG 54,FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 34卷 / 06期

关键词：

D O I：

10.1007/BF00615229

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：633 / 636

页数：4

共 11 条

[1]

JACOBO E, 1976, Urology, V8, P231, DOI 10.1016/0090-4295(76)90373-3

[2] DISPOSITION OF A NEW, NONSTEROID, ANTIANDROGEN, ALPHA,ALPHA,ALPHA-TRIFLUORO-2-METHYL-4'-NITRO-M-PROPIONOTOLUIDIDE (FLUTAMIDE), IN MEN FOLLOWING A SINGLE ORAL 200 MG DOSE [J].

KATCHEN, B ;

BUXBAUM, S .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 41 (02) :373-379

[3] ACTION OF A NONSTEROIDAL ANTIANDROGEN, FLUTAMIDE, ON RECEPTOR-BINDING AND NUCLEAR RETENTION OF 5-ALPHA DIHYDROTESTOSTERONE IN RAT VENTRAL PROSTATE [J].

LIAO, S ;

HOWELL, DK ;

CHANG, TM .

ENDOCRINOLOGY, 1974, 94 (04) :1205-1209

[4] BIOLOGICAL PROFILE OF A NONSTEROIDAL ANTIANDROGEN, SCH 13521 4'-NITRO-3'-TRIFLUOROMETHYLISOBUTYRANILIDE [J].

NERI, R ;

VANCLEAV.S ;

FLORANCE, K ;

KOZIOL, P .

ENDOCRINOLOGY, 1972, 91 (02) :427-&

[5]

NERI RO, 1972, INVEST UROL, V10, P123

[6] PROSTATIC CANCER AND SCH-13521 .2. HISTOLOGICAL ALTERATIONS AND PITUITARY GONADAL AXIS [J].

PROUT, GR ;

IRWIN, RJ ;

KLIMAN, B ;

DALY, JJ ;

MACLAUGHLIN, RA ;

GRIFFIN, PP .

JOURNAL OF UROLOGY, 1975, 113 (06) :834-840

[7] CHARACTERISTICS OF INTERACTION OF THE ANTIANDROGEN FLUTAMIDE WITH THE ANDROGEN RECEPTOR IN VARIOUS TARGET TISSUES [J].

SIMARD, J ;

LUTHY, I ;

GUAY, J ;

BELANGER, A ;

LABRIE, F .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1986, 44 (03) :261-270

[8]

Sogani P C, 1975, Urology, V6, P164, DOI 10.1016/0090-4295(75)90704-9

[9]

SOGANI PC, 1984, CANCER, V54, P744, DOI 10.1002/1097-0142(1984)54:4<744::AID-CNCR2820540426>3.0.CO

[10]

2-P

← 1 2 →